Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims

Product Liability / June 13, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , ,

One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood […]

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More ยป